日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rare penetrant mutations confer severe risk of common diseases

罕见的高外显率突变会带来罹患常见疾病的严重风险。

Fiziev, Petko; McRae, Jeremy; Ulirsch, Jacob C; Dron, Jacqueline S; Hamp, Tobias; Yang, Yanshen; Wainschtein, Pierrick; Ni, Zijian; Schraiber, Joshua G; Gao, Hong; Cable, Dylan; Field, Yair; Aguet, Francois; Fasnacht, Marc; Metwally, Ahmed; Rogers, Jeffrey; Marques-Bonet, Tomas; Rehm, Heidi L; O'Donnell-Luria, Anne; Khera, Amit V; Kai-How Farh, Kyle

Ruxolitinib reverses checkpoint inhibition by reducing programmed cell death ligand-1 (PD-L1) expression and increases anti-tumour effects of T cells in multiple myeloma

鲁索替尼通过降低程序性细胞死亡配体 1 (PD-L1) 表达来逆转检查点抑制,并增强多发性骨髓瘤中 T 细胞的抗肿瘤作用

Haiming Chen, Mingjie Li, Nicole Ng, Erin Yu, Sean Bujarski, Zhengyi Yin, Mingxiang Wen, Tara Hekmati, Dylan Field, Jasper Wang, Isabella Nassir, Janna Yu, Justin Huang, David Daniely, Cathy S Wang, Ning Xu, Tanya M Spektor, James R Berenson

Evoked potentials as a biomarker of remyelination

诱发电位作为髓鞘再生生物标志物

Heidari, Moones; Radcliff, Abigail B; McLellan, Gillian J; Ver Hoeve, James N; Chan, Kore; Kiland, Julie A; Keuler, Nicholas S; August, Benjamin K; Sebo, Dylan; Field, Aaron S; Duncan, Ian D